IV ketamine contains both mirror-image forms of the ketamine molecule and is delivered directly into the bloodstream through an IV. Its use for depression is off-label, and treatment schedules can be individualized by the prescribing clinician. For the right patient, IV ketamine allows us to treat conditions other than just treatment resistant depression.
Spravato® contains esketamine, one specific form of the ketamine molecule. It is an FDA-approved nasal spray for certain adults with depression and must be administered in a certified healthcare setting under a safety-monitoring program. Our clinic is fully certified under the REMS program. Spravato® is covered under most major health insurance carriers, including Medicaid and Medicare.
Both treatments can cause temporary sleepiness, dissociation, dizziness, and increased blood pressure, which our team monitors during your treatment session. The best option depends on your diagnosis, treatment history, medical needs, insurance benefits, and preferences.